Macroglial Plasticity and the Origins of Reactive Astroglia in Experimental Autoimmune Encephalomyelitis

被引:58
|
作者
Guo, Fuzheng [1 ,2 ]
Maeda, Yoshiko [1 ,2 ]
Ma, Joyce [1 ,2 ]
Delgado, Monica [1 ,2 ]
Sohn, Jiho [1 ,2 ]
Miers, Laird [1 ,2 ]
Ko, Emily Mills [1 ,2 ]
Bannerman, Peter [1 ,2 ]
Xu, Jie [1 ,2 ]
Wang, Yazhou [1 ,2 ]
Zhou, Chengji [1 ,2 ]
Takebayashi, Hirohide [3 ]
Pleasure, David [1 ,2 ]
机构
[1] Univ Calif Davis, Sch Med, Inst Pediat Regenerat Med, Sacramento, CA 95817 USA
[2] Shriners Hosp Crippled Children, Sacramento, CA 95817 USA
[3] Kumamoto Univ, Grad Sch Med Sci, Dept Morphol Neural Sci, Kumamoto 8608556, Japan
来源
JOURNAL OF NEUROSCIENCE | 2011年 / 31卷 / 33期
关键词
NEURAL STEM-CELLS; TRANSCRIPTION FACTOR OLIG2; SPINAL-CORD; PROGENITOR CELLS; GLIA GENERATE; GRAY-MATTER; ASTROCYTES; BRAIN; OLIGODENDROCYTES; LINEAGE;
D O I
10.1523/JNEUROSCI.1759-11.2011
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Accumulations of hypertrophic, intensely glial fibrillary acidic protein-positive (GFAP(+)) astroglia, which also express immunoreactive nestin and vimentin, are prominent features of multiple sclerosis lesions. The issues of the cellular origin of hypertrophic GFAP(+)/vimentin(+)/nestin(+) "reactive" astroglia and also the plasticities and lineage relationships among three macroglial progenitor populations-oligodendrocyte progenitor cells (OPCs), astrocytes and ependymal cells-during multiple sclerosis and other CNS diseases remain controversial. We used genetic fate-mappings with a battery of inducible Cre drivers (Olig2-Cre-ERT2, GFAP-Cre-ERT2, FoxJ1-Cre-ERT2 and Nestin-Cre-ERT2) to explore these issues in adult mice with myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis (EAE). The proliferative rate of spinal cord OPCs rose fivefold above control levels during EAE, and numbers of oligodendroglia increased as well, but astrogenesis from OPCs was rare. Spinal cord ependymal cells, previously reported to be multipotent, did not augment their low proliferative rate, nor give rise to astroglia or OPCs. Instead, the hypertrophic, vimentin(+)/nestin(+), reactive astroglia that accumulated in spinal cord in this multiple sclerosis model were derived by proliferation and phenotypic transformation of fibrous astroglia in white matter, and solely by phenotypic transformation of protoplasmic astroglia in gray matter. This comprehensive analysis of macroglial plasticity in EAE helps to clarify the origins of astrogliosis in CNS inflammatory demyelinative disorders.
引用
收藏
页码:11914 / 11928
页数:15
相关论文
共 50 条
  • [31] REINDUCTION OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN MICE
    LINDSEY, JW
    PAPPOLLA, M
    STEINMAN, L
    CELLULAR IMMUNOLOGY, 1995, 162 (02) : 235 - 240
  • [32] The origin and application of experimental autoimmune encephalomyelitis
    Baxter, Alan G.
    NATURE REVIEWS IMMUNOLOGY, 2007, 7 (11) : 904 - 912
  • [33] Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis
    Shin, Taekyun
    Ahn, Meejung
    Moon, Changjong
    Kim, Seungjoon
    ANATOMY & CELL BIOLOGY, 2012, 45 (04) : 215 - 220
  • [34] Fas in murine experimental autoimmune encephalomyelitis
    Ho, PP
    Tse, HY
    FASEB JOURNAL, 1999, 13 (05): : A1002 - A1002
  • [35] Effect a minocycline in experimental autoimmune encephalomyelitis
    Nessler, S
    Dodel, R
    Bittner, A
    Reuss, S
    Du, YS
    Hemmer, B
    Sommer, N
    ANNALS OF NEUROLOGY, 2002, 52 (05) : 689 - 690
  • [36] Role of proteoglycan in experimental autoimmune encephalomyelitis
    Inada, R.
    Miyamoto, K.
    Moriguchi, K.
    Kadomatsu, K.
    Takeuchi, K.
    Igarashi, M.
    Kusunoki, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 441 - 441
  • [37] Gene Therapy in Experimental Autoimmune Encephalomyelitis
    Peter M. Mathisen
    Vincent K. Tuohy
    Journal of Clinical Immunology, 2000, 20 : 327 - 333
  • [38] The origin and application of experimental autoimmune encephalomyelitis
    Alan G. Baxter
    Nature Reviews Immunology, 2007, 7 : 904 - 912
  • [39] SUPPRESSION OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS BY CANNABINOIDS
    WIRGUIN, I
    MECHOULAM, R
    BREUER, A
    SCHEZEN, E
    WEIDENFELD, J
    BRENNER, T
    IMMUNOPHARMACOLOGY, 1994, 28 (03): : 209 - 214
  • [40] Oral tolerance in experimental autoimmune encephalomyelitis
    Whitacre, CC
    Gienapp, IE
    Meyer, A
    Cox, KL
    Javed, N
    ORAL TOLERANCE: MECHANISMS AND APPLICATIONS, 1996, 778 : 217 - 227